Meeting
2018 ASCO Annual Meeting
NKG2D chimeric antigen receptor-T cells to target GBM.
Authors
Hong-jiu Dai
Nanjing Kaedi Biotech Inc, Nanjing, China
Hong-jiu Dai , Lan Shi , Pei-xian Zhang , Xu-dong Zhao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2034)
DOI
10.1200/JCO.2018.36.15_suppl.2034
Abstract #
2034
Poster Bd #
192
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Eradication of medulloblastoma by NKG2D-specific CAR T-cells.
First Author: Hong-jiu Dai
Poster
2016 ASCO Annual Meeting
A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma.
First Author: Sarah Nikiforow
Poster
2022 ASCO Genitourinary Cancers Symposium
Immune characterization of urothelial bladder carcinoma integrating transurethral resection of bladder tumor (TURBT) samples and serum: A feasibility study.
First Author: Carmen Alvarez-Dominguez
First Author: Patrick Roth